Kruse Bo
EVP, CFO, SECRY & TREAS. at Y-mAbs Therapeutics, Inc.
- Sold, on record
- $6.3M
- Dollars the filings state
- Form 4 sales
- 21
- Latest May 31, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Y-mAbs Therapeutics, Inc.EVP, CFO, SECRY & TREAS.
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not statedNov 22 2021
Sold 4,000 shares at $18.09 ($72k)
Kruse Bo, EVP, CFO, Secretary & Treas.
Sold 1.9% of holdings ($3.8M position)205,077 shares left1x usual sizeFiling
- 2 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not statedDec 6 +14 days
Sold 4,000 shares at $16.35 ($65k)
Kruse Bo, EVP, CFO, Secretary & Treas.
Sold 2% of holdings ($3.4M position)201,077 shares left1x usual sizeFiling
- 3 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not statedDec 22 +16 days
Sold 4,000 shares at $16.36 ($65k)
Kruse Bo, EVP, CFO, Secretary & Treas.
Sold 2% of holdings ($3.3M position)197,077 shares left1x usual sizeFiling
- 4 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not statedJan 4 +13 days
Sold 4,000 shares at $17.12 ($68k)
Kruse Bo, EVP, CFO, Secretary & Treas.
Sold 2% of holdings ($3.4M position)193,077 shares left1x usual sizeFiling
- 5 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not statedJan 24 +20 days
Sold 4,000 shares at $9.84 ($39k)
Kruse Bo, EVP, CFO, Secretary & Treas.
Sold 2.1% of holdings ($1.9M position)189,077 shares left1x usual sizeFiling
- 6 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not statedFeb 4 +11 days
Sold 4,000 shares at $7.97 ($32k)
Kruse Bo, EVP, CFO, Secretary & Treas
Sold 2.1% of holdings ($1.5M position)185,077 shares left1x usual sizeFiling
- 7 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not statedFeb 22 +18 days
Sold 4,000 shares at $7.85 ($31k)
Kruse Bo, EVP, CFO, Secretary & Treas.
Sold 2.2% of holdings ($1.5M position)181,077 shares left1x usual sizeFiling
- 8 Form 4 sale Y-mAbs Therapeutics, Inc.No planMay 31 +829 days
Sold 60,000 shares at $12.05 ($723k)
Kruse Bo, EVP, CFO, SECRY & TREAS.
No 10b5-1 planSold 22.2% of holdings ($3.3M position)210,877 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (21)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| May 31, 2024 | Y-mAbs Therapeutics, Inc. | EVP, CFO, SECRY & TREAS. | Form 4 sale | 60,000 | $723k | 22.2% | No plan | SEC |
| Feb 22, 2022 | Y-mAbs Therapeutics, Inc. | EVP, CFO, Secretary & Treas. | Form 4 sale | 4,000 | $31k | 2.2% | Plan not stated | SEC |
| Feb 4, 2022 | Y-mAbs Therapeutics, Inc. | EVP, CFO, Secretary & Treas | Form 4 sale | 4,000 | $32k | 2.1% | Plan not stated | SEC |
| Jan 24, 2022 | Y-mAbs Therapeutics, Inc. | EVP, CFO, Secretary & Treas. | Form 4 sale | 4,000 | $39k | 2.1% | Plan not stated | SEC |
| Jan 4, 2022 | Y-mAbs Therapeutics, Inc. | EVP, CFO, Secretary & Treas. | Form 4 sale | 4,000 | $68k | 2.0% | Plan not stated | SEC |
| Dec 22, 2021 | Y-mAbs Therapeutics, Inc. | EVP, CFO, Secretary & Treas. | Form 4 sale | 4,000 | $65k | 2.0% | Plan not stated | SEC |
| Dec 6, 2021 | Y-mAbs Therapeutics, Inc. | EVP, CFO, Secretary & Treas. | Form 4 sale | 4,000 | $65k | 2.0% | Plan not stated | SEC |
| Nov 22, 2021 | Y-mAbs Therapeutics, Inc. | EVP, CFO, Secretary & Treas. | Form 4 sale | 4,000 | $72k | 1.9% | Plan not stated | SEC |
| Nov 4, 2021 | Y-mAbs Therapeutics, Inc. | EVP, CFO, Secretary & Treas. | Form 4 sale | 4,000 | $110k | 1.9% | Plan not stated | SEC |
| Oct 22, 2021 | Y-mAbs Therapeutics, Inc. | EVP, CFO, Secretary & Treas. | Form 4 sale | 4,000 | $104k | 1.8% | Plan not stated | SEC |
| Oct 4, 2021 | Y-mAbs Therapeutics, Inc. | EVP, CFO, Secretary & Treas. | Form 4 sale | 4,000 | $115k | 1.8% | Plan not stated | SEC |
| Sep 22, 2021 | Y-mAbs Therapeutics, Inc. | EVP, CFO, Secretary & Treas. | Form 4 sale | 4,000 | $123k | 1.8% | Plan not stated | SEC |
| Sep 7, 2021 | Y-mAbs Therapeutics, Inc. | EVP, CFO, Secretary & Treas. | Form 4 sale | 4,000 | $128k | 1.7% | Plan not stated | SEC |
| Aug 23, 2021 | Y-mAbs Therapeutics, Inc. | EVP, CFO, Secretary & Treas. | Form 4 sale | 4,000 | $114k | 1.7% | Plan not stated | SEC |
| Aug 4, 2021 | Y-mAbs Therapeutics, Inc. | EVP, CFO, Secretary & Treas. | Form 4 sale | 4,000 | $135k | 1.7% | Plan not stated | SEC |
| Jul 22, 2021 | Y-mAbs Therapeutics, Inc. | EVP, CFO, Secretary & Treas. | Form 4 sale | 4,000 | $138k | 1.7% | Plan not stated | SEC |
| Jul 6, 2021 | Y-mAbs Therapeutics, Inc. | EVP, CFO, Secretary & Treas. | Form 4 sale | 4,000 | $137k | 1.6% | Plan not stated | SEC |
| Jun 22, 2021 | Y-mAbs Therapeutics, Inc. | EVP, CFO, Secretary & Treas. | Form 4 sale | 4,000 | $145k | 1.6% | Plan not stated | SEC |
| Jun 4, 2021 | Y-mAbs Therapeutics, Inc. | EVP, CFO, Secretary & Treas. | Form 4 sale | 4,000 | $134k | 1.6% | Plan not stated | SEC |
| May 24, 2021 | Y-mAbs Therapeutics, Inc. | EVP, CFO, Secretary & Treas. | Form 4 sale | 4,000 | $142k | 1.6% | Plan not stated | SEC |
| May 14, 2020 | Y-mAbs Therapeutics, Inc. | EVP, CFO, Secy & Treas. | Form 4 sale | 100,000 | $3.7M | 28.0% | Unusual | SEC |